Andrew Haydon

Adj Assoc Prof

20022025

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Effect of direct-current magnetic field on the specific absorption rate of metamagnetic CoMnSi: a potential approach to switchable hyperthermia therapy

Ugochukwu, K. C., Sadiq, M. M., Biegel, E. S., Meagher, L., Hill, M. R., Sandeman, K. G., Haydon, A. & Suzuki, K., Jan 2020, In : AIP Advances. 10, 1, 7 p., 015128.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Metastatic melanoma presenting as intravenous tumourthrombus

Nguyen, J., Clements, W., McLean, C., Haydon, A., Moore, M., Yap, K. SK., Mar, V. & Shackleton, M., 7 Feb 2020, (Accepted/In press) In : Journal of Medical Imaging and Radiation Oncology. 3 p.

Research output: Contribution to journalArticleOtherpeer-review

2019

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

Schadendorf, D., Hauschild, A., Santinami, M., Atkinson, V., Mandalà, M., Chiarion-Sileni, V., Larkin, J., Nyakas, M., Dutriaux, C., Haydon, A., Robert, C., Mortier, L., Lesimple, T., Plummer, R., Schachter, J., Dasgupta, K., Manson, S., Koruth, R., Mookerjee, B., Kefford, R. & 3 others, Dummer, R., Kirkwood, J. M. & Long, G. V., 1 May 2019, In : The Lancet Oncology. 20, 5, p. 701-710 10 p.

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA

Tan, L., Sandhu, S., Lee, R. J., Li, J., Callahan, J., Ftouni, S., Dhomen, N., Middlehurst, P., Wallace, A., Raleigh, J., Hatzimihalis, A., Henderson, M. A., Shackleton, M., Haydon, A., Mar, V., Gyorki, D. E., Oudit, D., Dawson, M. A., Hicks, R. J., Lorigan, P. & 4 others, McArthur, G. A., Marais, R., Wong, S. Q. & Dawson, S. J., 1 May 2019, In : Annals of Oncology. 30, 5, p. 804-814 11 p.

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. JM. & 12 others, Grob, J. J., Gutzmer, R., Jamal, R., Lorigan, P. C., Lupinacci, R., Krepler, C., Ibrahim, N., Kicinski, M., Marreaud, S., van Akkooi, A. C., Suciu, S. & Robert, C., 1 Jul 2019, In : European Journal of Cancer. 116, p. 148-157 10 p.

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: A prospective biomarker study

Tie, J., Cohen, J. D., Wang, Y., Li, L., Christie, M., Simons, K., Elsaleh, H., Kosmider, S., Wong, R., Yip, D., Lee, M., Tran, B., Rangiah, D., Burge, M., Goldstein, D., Singh, M., Skinner, I., Faragher, I., Croxford, M., Bampton, C. & 14 others, Haydon, A., Jones, I. T., S Karapetis, C., Price, T., Schaefer, M. J., Ptak, J., Dobbyn, L., Silliman, N., Kinde, I., Tomasetti, C., Papadopoulos, N., Kinzler, K., Volgestein, B. & Gibbs, P., 1 Apr 2019, In : Gut. 68, 4, p. 663-671 9 p.

Research output: Contribution to journalArticleResearchpeer-review

43 Citations (Scopus)

The Upper Gastrointestinal Cancer Registry (UGICR): A clinical quality registry to monitor and improve care in upper gastrointestinal cancers

Maharaj, A. D., Holland, J. F., Scarborough, R. O., Evans, S. M., Ioannou, L. J., Brown, W., Croagh, D. G., Pilgrim, C. H. C., Kench, J. G., Lipton, L. R., Leong, T., McNeil, J. J., Nikfarjam, M., Aly, A., Burton, P. R., Cashin, P. A., Chu, J., Duong, C. P., Evans, P., Goldstein, D. & 12 others, Haydon, A., Hii, M. W., Knowles, B. P. F., Merrett, N. D., Michael, M., Neale, R. E., Philip, J., Porter, I. W. T., Smith, M., Spillane, J., Tagkalidis, P. P. & Zalcberg, J. R., 1 Sep 2019, In : BMJ Open. 9, 9, 11 p., e031434.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
2018

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Iveson, T. J., Kerr, R. S., Saunders, M. P., Cassidy, J., Hollander, N. H., Tabernero, J., Haydon, A., Glimelius, B., Harkin, A., Allan, K., McQueen, J., Scudder, C., Boyd, K. A., Briggs, A., Waterston, A., Medley, L., Wilson, C., Ellis, R., Essapen, S., Dhadda, A. S. & 16 others, Harrison, M., Falk, S., Raouf, S., Rees, C., Olesen, R. K., Propper, D., Bridgewater, J., Azzabi, A., Farrugia, D., Webb, A., Cunningham, D., Hickish, T., Weaver, A., Gollins, S., Wasan, H. S. & Paul, J., 1 Apr 2018, In : The Lancet Oncology. 19, 4, p. 562-578 17 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
46 Citations (Scopus)

Adjuvant pembrolizumab versus placebo in resected stage III melanoma

Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Maio, M., Van Den Eertwegh, A. J. M. & 9 others, Grob, J. J., Gutzmer, R., Jamal, R., Lorigan, P., Ibrahim, N., Marreaud, S., Van Akkooi, A. C. J., Suciu, S. & Robert, C., 10 May 2018, In : The New England Journal of Medicine. 378, 19, p. 1789-1801 13 p.

Research output: Contribution to journalArticleResearchpeer-review

358 Citations (Scopus)

Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Maio, M., Lewis, K., Demidov, L., Mandalà, M., Bondarenko, I., Ascierto, P., Herbert, C., Mackiewicz, A., Rutkowski, P., Guminski, A., Goodman, G. R., Simmons, B., Ye, C., Yan, Y. & BRIM8 Investigators, 1 Apr 2018, In : The Lancet Oncology. 19, 4, p. 510-520 11 p.

Research output: Contribution to journalArticleResearchpeer-review

53 Citations (Scopus)

Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype

Jayasekara, H., English, D. R., Haydon, A., Hodge, A. M., Lynch, B. M., Rosty, C., Williamson, E. J., Clendenning, M., Southey, M. C., Jenkins, M. A., Room, R., Hopper, J. L., Milne, R. L., Buchanan, D. D., Giles, G. G. & MacInnis, R. J., 15 Jan 2018, In : International Journal of Cancer. 142, 2, p. 238-250 13 p.

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Clinicopathological characteristics and prognosis of patients with multiple primary melanomas

Adler, N. R., Kelly, J. W., Haydon, A., McLean, C. A. & Mar, V. J., 1 Jan 2018, In : British Journal of Dermatology. 178, 1, p. e44-e45 2 p.

Research output: Contribution to journalLetterOtherpeer-review

2 Citations (Scopus)

Concordance of somatic mutational profile in multiple primary melanomas

Adler, N. R., McLean, C. A., Wolfe, R., Kelly, J. W., McArthur, G. A., Haydon, A., Tra, T., Cummings, N. & Mar, V. J., 1 Sep 2018, In : Pigment Cell and Melanoma Research. 31, 5, p. 592-603 12 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy

Chandrasekara, S., Davis, S., Thomson, P. & Haydon, A., 1 Oct 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, 5, p. e442-e447 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres

Grant, M., Haydon, A., Au, L., Wilkins, S., Oliva, K., Segelov, E., Antill, Y., Carne, P., Ranchod, P., Polglase, A., Farmer, C., Chin, M., Wale, R., Simpson, P., Bell, S., Skinner, S., McMurrick, P. & Shapiro, J., 1 Mar 2018, In : International Journal of Surgery. 51, p. 71-75 5 p.

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600–mutant stage III melanoma

Hauschild, A., Dummer, R., Schadendorf, D., Santinami, M., Atkinson, V., Mandalà, M., Chiarion-Sileni, V., Larkin, J., Nyakas, M., Dutriaux, C., Haydon, A., Robert, C., Mortier, L., Schachter, J., Lesimple, T., Plummer, R., Dasgupta, K., Haas, T., Shilkrut, M., Gasal, E. & 3 others, Kefford, R., Kirkwood, J. M. & Long, G. V., 10 Dec 2018, In : Journal of Clinical Oncology. 36, 35, p. 3441-3449 9 p.

Research output: Contribution to journalArticleResearchpeer-review

59 Citations (Scopus)

Patients’ preferences for 3 months versus 6 months of adjuvant chemotherapy (ACT) for colon cancer in the SCOT trial: what survival benefits make longer chemotherapy worthwhile?

Segelov, E., Blinman, P., Martin, A., Goldstein, D., Cronk, M., Boadle, D., Tebbutt, N., Paul, J. & Haydon, A., 2018.

Research output: Contribution to conferenceAbstract

Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics

Luen, S., Wong, S. W., Mar, V., Kelly, J. W., McLean, C., McArthur, G. A. & Haydon, A., 1 Jan 2018, In : American Journal of Clinical Oncology. 41, 1, p. 90-94 5 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy

Adler, N. R., Wolfe, R., McArthur, G. A., Kelly, J. W., Haydon, A., McLean, C. A. & Mar, V. J., 1 May 2018, In : British Journal of Cancer. 118, 10, p. 1289-1295 7 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)
2017

Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma

Long, G. V., Hauschild, A., Santinami, M., Atkinson, V., Mandal, M., Chiarion-Sileni, V., Larkin, J., Nyakas, M., Dutriaux, C., Haydon, A., Robert, C., Mortier, L., Schachter, J., Schadendorf, D., Lesimple, T., Plummer, R., Ji, R., Zhang, P., Mookerjee, B., Legos, J. & 3 others, Kefford, R., Dummer, R. & Kirkwood, J. M., 9 Nov 2017, In : The New England Journal of Medicine. 377, 19, p. 1813-1823 11 p.

Research output: Contribution to journalArticleResearchpeer-review

414 Citations (Scopus)

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases

Parakh, S., Park, J. J., Mendis, S., Rai, R., Xu, W., Lo, S., Drummond, M., Rowe, C., Wong, A., McArthur, G., Haydon, A., Andrews, M. C., Cebon, J., Guminski, A., Kefford, R. F., Long, G. V., Menzies, A. M., Klein, O. & Carlino, M. S., 6 Jun 2017, In : British Journal of Cancer. 116, 12, p. 1558-1563 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
41 Citations (Scopus)

Metastatic pathways in patients with cutaneous melanoma

Adler, N. R., Haydon, A., McLean, C. A., Kelly, J. W. & Mar, V. J., 1 Jan 2017, In : Pigment Cell and Melanoma Research. 30, 1, p. 13-27 15 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

19 Citations (Scopus)

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy

Tay, R. Y., Blackley, E., McLean, C., Moore, M., Bergin, P., Gill, S. & Haydon, A., 26 Sep 2017, In : British Journal of Cancer. 117, 7, p. 921-924 4 p.

Research output: Contribution to journalArticleOtherpeer-review

24 Citations (Scopus)

The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation- analysis of outcomes in patients with “Quad WT”. J Clin Oncol 35 (15) 3572.

Segelov, E., Shapiro, J., Thavaneswaran, S., Waring, P., Desai, J., Mann, K., Elez, M. E., Chantrill, L. A., Pavlakis, N., Nott, L., Underhill, C., Khasraw, M., Wasan, H., Ciardiello, F., Jefford, M. J., Joubert, W., Haydon, A. M. M., Karapetis, C., Price, T. J. & Wilson, K., 2017, p. 3572 . 1 p.

Research output: Contribution to conferencePoster

Tumour mutation status and sites of metastasis in patients with cutaneous melanoma

Adler, N. R., Wolfe, R., Kelly, J. W., Haydon, A., McArthur, G. A., McLean, C. A. & Mar, V. J., 26 Sep 2017, In : British Journal of Cancer. 117, 7, p. 1026-1035 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
11 Citations (Scopus)
2016

A randomized controlled trial of a nurse-led supportive care package (Survivorcare) for survivors of colorectal cancer

Jefford, M., Gough, K., Dowsky, A., Russell, L., Aranda, S., Butow, P., Phipps-Nelson, J., Young, J., Krishnasamy, M., Ugalde, A., King, D., Strickland, A., Franco, M., Blum, R., Johnson, C., Ganju, V., Shapiro, J., Chong, G., Charlton, J., Haydon, A. & 1 others, Schofield, P., 1 Aug 2016, In : Oncologist. 21, 8, p. 1014-1023 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
25 Citations (Scopus)

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H-L., Christie, M., Kosmider, S., Skinner, I., Wong, R., Steel, M., Tran, B., Desai, J., Jones, I., Haydon, A., Hayes, T., Price, T. J. & 6 others, Strausberg, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B. & Gibbs, P., 6 Jul 2016, In : Science Translational Medicine. 8, 346, p. 1-10 10 p., 346ra92.

Research output: Contribution to journalArticleResearchpeer-review

363 Citations (Scopus)

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases

Park, J. J., Parakh, S., Mendis, S., Rai, R., Lo, S., Haydon, A., Andrews, M. C., Cebon, J., Guminski, A., Kefford, R., Long, G. V., Menzies, A. M., Klein, O. & Carlino, M. S., 1 Oct 2016, In : Annals of Oncology. 27, p. vi382 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Open Access

ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

Segelov, E., Waring, P., Desai, J., Wilson, K., Gebski, V., Thavaneswaran, S., Elez, E., Underhill, C., Pavlakis, N., Chantrill, L., Nott, L., Jefford, M., Khasraw, M., Day, F., Wasan, H., Ciardiello, F., Karapetis, C., Joubert, W., Hazel, G., Haydon, A. & 4 others, Price, T., Tejpar, S., Tebbutt, N. & Shapiro, J., 31 May 2016, In : BMC Cancer. 16, 1, 339.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
6 Citations (Scopus)

Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists

Atkinson, V., Long, G. V., Menzies, A. M., McArthur, G., Carlino, M. S., Millward, M., Roberts-Thomson, R., Brady, B., Kefford, R., Haydon, A. & Cebon, J., 1 Dec 2016, In : Asia-Pacific Journal of Clinical Oncology. 12, p. 5-12 8 p.

Research output: Contribution to journalArticleOtherpeer-review

8 Citations (Scopus)

Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian gastro-intestinal trials group ICECREAM study

Segelov, E., Thavaneswaran, S., Waring, P. M., Desai, J., Robledo, K. P., Gebski, V. J., Elez, E., Nott, L. M., Karapetis, C. S., Lunke, S., Chantrill, L. A., Pavlakis, N., Khasraw, M., Underhill, C., Ciardiello, F., Jefford, M., Wasan, H., Haydon, A., Price, T. J., Van Hazel, G. & 3 others, Wilson, K., Simes, J. & Shapiro, J. D., 1 Jul 2016, In : Journal of Clinical Oncology. 34, 19, p. 2258-2264 7 p.

Research output: Contribution to journalArticleResearchpeer-review

26 Citations (Scopus)

The Victorian Melanoma Service: A 20-year review of an Australian multidisciplinary cancer service

Meani, R. E., Pan, Y., McLean, C., Haydon, A., Leung, M. & Kelly, J. W., 1 Aug 2016, In : Australasian Journal of Dermatology. 57, 3, p. 235-237 3 p.

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)
2015

Advanced melanoma: The changing landscape of treatment

Haydon, A. & Moore, M., 1 Jan 2015, In : Medicine Today. 16, 9, p. 58-61 4 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Hersh, E. M., Del Vecchio, M., Brown, M. P., Kefford, R., Loquai, C., Testori, A., Bhatia, S., Gutzmer, R., Conry, R., Haydon, A., Robert, C., Ernst, S., Homsi, J., Grob, J. J., Kendra, K., Agarwala, S. S., Li, M., Clawson, A., Brachmann, C., Karnoub, M. & 3 others, Elias, I., Renschler, M. F. & Hauschild, A., 1 Nov 2015, In : Annals of Oncology. 26, 11, p. 2267-2274 8 p., mdv324.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
28 Citations (Scopus)

Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX(tm) vaccine in patients with advanced melanoma

Klein, O., Davis, I., McArthur, G. A., Chen, L., Haydon, A. M., Parente, P., Dimopoulos, N., Jackson, H., Xiao, K., Maraskovsky, E., Hopkins, W., Stan, R., Chen, W. & Cebon, J., 2015, In : Cancer Immunology Immunotherapy. 64, 4, p. 507 - 518 12 p.

Research output: Contribution to journalArticleResearchpeer-review

23 Citations (Scopus)

Prognosis associated with cutaneous melanoma metastases

Pan, Y., Haydon, A. M., McLean, C. A., McDonald, P. B. B. & Kelly, J. W., 1 Jan 2015, In : Australasian Journal of Dermatology. 56, 1, p. 25-28 4 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation- analysis of outcomes in patients with refractory metastatic colorectal cancer harbouring the KRAS G13D mutation.

Segelov, E., Thavaneswaran, S., Waring, P., Desai, J., Mann, K., Elez, M. E., Chantrill, L. A., Pavlakis, N., Nott, L., Underhill, C., Khasraw, M., Wasan, H., Ciardiello, F., Jefford, M. J., Joubert, W., Haydon, A. M. M., Karapetis, C., Price, T. J., Wilson, K. & Shapiro, J., 2015, p. S726. 1 p.

Research output: Contribution to conferenceAbstract

2014

Ideal care and the realities of practice: Interdisciplinary relationships in the management of advanced cancer patients in Australian emergency departments

Lane, H., Weil, J., Jelinek, G. A., Boughey, M., Marck, C. H., Weiland, T. J., Haydon, A. & Philip, J., Apr 2014, In : Supportive Care in Cancer. 22, 4, p. 1029-1035 7 p.

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry

Stirling, R. G., Evans, S. M., McLaughlin, P., Senthuren, M., Millar, J., Gooi, J., Irving, L. B., Mitchell, P., Haydon, A. M., Ruben, J. D., Conron, M., Leong, T., Watkins, D. N. & McNeil, J. J., 2014, In : Lung. 192, 5, p. 749 - 758 10 p.

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)
2013

Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype

Walsh, M. D., Clendenning, M., Williamson, E., Pearson, S. A., Walters, R. J., Nagler, B., Packenas, D., Win, A. K., Hopper, J. L., Jenkins, M. A., Haydon, A. M., Rosty, C., English, D. R., Giles, G. G., McGuckin, M. A., Young, J. P. & Buchanan, D. D., Dec 2013, In : Modern Pathology. 26, 12, p. 1642-1656 15 p.

Research output: Contribution to journalArticleResearchpeer-review

79 Citations (Scopus)

Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009

Wong, N., Haydon, A., Kemp, W., Wijeratne, P. & Roberts, S., 1 Feb 2013, In : Internal Medicine Journal. 43, 2, p. 197-203 7 p.

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 trial

Siu, L. L., Shapiro, J. D., Jonker, D. J., Karapetis, C. S., Zalcberg, J. R., Simes, J., Couture, F., Moore, M. J., Price, T. J., Siddiqui, J., Nott, L. M., Charpentier, D., Liauw, W., Sawyer, M. B., Jefford, M., Magoski, N. M., Haydon, A., Walters, I., Ringash, J., Tu, D. & 1 others, O'Callaghan, C. J., 1 Jul 2013, In : Journal of Clinical Oncology. 31, 19, p. 2477-2484 8 p.

Research output: Contribution to journalArticleResearchpeer-review

83 Citations (Scopus)

Size of anal squamous cell carcinomas at diagnosis: a retrospective case series

Read, T. R. H., Huson, K. L., Millar, J., Haydon, A., Porter, I. W. T., Grulich, A., Hocking, J., Chen, M. Y., Bradshaw, C. & Fairley, C., 2013, In : International Journal of STD and AIDS. 24, 11, p. 879 - 882 4 p.

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)
2011
4 Citations (Scopus)

Investigation of the safety of irreversible electroporation in humans

Thomson, K. R., Cheung, W., Ellis, S. J., Federman, D., Kavnoudias, H., Loader-Oliver, D., Roberts, S. K., Evans, P. M., Ball, C. M. & Haydon, A. M., 2011, In : Journal of Vascular and Interventional Radiology. 22, 5, p. 611 - 621 11 p.

Research output: Contribution to journalArticleResearchpeer-review

317 Citations (Scopus)
2010

The role of SMAD4 in early-onset colorectal cancer

Royce, S., Alsop, K., Haydon, A., Mead, L., Smith, L. D., Tesoriero, A., Giles, G., Jenkins, M., Hopper, J. & Southey, M., 2010, In : Colorectal Disease. 12, 3, p. 213 - 219 7 p.

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)
2009

O6-methylguanine-DNA methyltransferase depletion and DNA damage in patients with advanced melanoma treated with temozolomide alone or in combination with lomeguatrib.

Watson, A. J., Middleton, M. R., McGown, G., Thorncroft, M., Ranson, M., Hersey, P., McArthur, G., Davis, I., Thomson, D., Beith, J., Haydon, A., Kefford, R., Lorigan, P., Mortimer, P., Sabharwal, A., Hayward, O. & Margison, GP., 2009, In : British Journal of Cancer. 100, p. 1250 - 1256 7 p.

Research output: Contribution to journalArticleResearchpeer-review

31 Citations (Scopus)

The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort study

Kelsall, H. L., Baglietto, L., Muller, D., Haydon, A. M., English, D. & Giles, G., 2009, In : Social Science and Medicine. 68, 2, p. 290 - 297 8 p.

Research output: Contribution to journalArticleResearchpeer-review

35 Citations (Scopus)
2008

A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma

Lewis, K. D., Robinson, W. A., Millward, M. J., Powell, A., Price, T. J., Thomson, D. B., Walpole, E. T., Haydon, A. M., Creese, B. R., Roberts, K. L., Zalcberg, J. R. & Gonzalez, R., 1 Feb 2008, In : Investigational New Drugs. 26, 1, p. 89-94 6 p.

Research output: Contribution to journalArticleResearchpeer-review

57 Citations (Scopus)